Cargando…

Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells

BACKGROUND: High-grade non-muscle invasive bladder cancer (NMIBC) has a high risk of recurrence and progression to muscle-invasive forms, which seems to be largely related to the presence of tumorigenic stem-like cell populations that are refractory to conventional therapies. Here, we evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira-Teixeira, Margarida, Paiva-Oliveira, Daniela, Parada, Belmiro, Alves, Vera, Sousa, Vitor, Chijioke, Obinna, Münz, Christian, Reis, Flávio, Rodrigues-Santos, Paulo, Gomes, Célia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075212/ https://www.ncbi.nlm.nih.gov/pubmed/27769244 http://dx.doi.org/10.1186/s12916-016-0715-2

Ejemplares similares

Natural killer cells in herpesvirus infections
por: Münz, Christian, et al.
Publicado: (2017)

Interactions of Human Myeloid Cells with Natural Killer Cell Subsets In Vitro and In Vivo
por: Chijioke, Obinna, et al.
Publicado: (2011)

Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013)

Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors
por: Ferreira-Teixeira, Margarida, et al.
Publicado: (2015)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
por: Kisseberth, William C., et al.
Publicado: (2021)

Adoptive Transfer of EBV Specific CD8(+) T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
por: Antsiferova, Olga, et al.
Publicado: (2014)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
por: Murer, Anita, et al.
Publicado: (2019)

Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report
por: Kimura, Hideki, et al.
Publicado: (2008)

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
por: Matosevic, Sandro
Publicado: (2018)

Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo”
por: Murer, Anita, et al.
Publicado: (2019)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

Natural Killer Cell Responses during Human γ-Herpesvirus Infections
por: Münz, Christian
Publicado: (2021)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
por: Schmeel, Frederic Carsten, et al.
Publicado: (2014)

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer
por: Chen, Dan, et al.
Publicado: (2018)

Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer
por: Obajdin, J., et al.
Publicado: (2020)

Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
por: GRANZIN, MARKUS, et al.
Publicado: (2015)

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
por: Caduff, Nicole, et al.
Publicado: (2021)

Adoptive Immunotherapy of Cytokine-Induced Killer Cell Therapy in the Treatment of Non-Small Cell Lung Cancer
por: Wang, Min, et al.
Publicado: (2014)

Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox
por: Xiao, Jiani, et al.
Publicado: (2022)

Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model
por: Sereno, José, et al.
Publicado: (2012)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2020)

Adoptive immunotherapy for gastric cancer using zoledronate-activated killer cells: A prospective observational study
por: Yamaguchi, Yoshiyuki, et al.
Publicado: (2022)

Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma
por: Zheng, Youshi, et al.
Publicado: (2023)

Bortezomib sensitizes human glioblastoma stem cells to adoptive natural killer cell cytotoxicity
por: Grossenbacher, Steven, et al.
Publicado: (2015)

Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters
por: Parisi, Sarah, et al.
Publicado: (2022)

Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia
por: Trombetti, Silvia, et al.
Publicado: (2021)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo
Publicado: (1985)

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer
por: Sabry, May, et al.
Publicado: (2020)

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
por: Nakamura, Y., et al.
Publicado: (1992)

Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells
por: Sommaggio, Roberta, et al.
Publicado: (2020)

Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Hattori, Norimichi, et al.
Publicado: (2019)

Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma
por: Tong, Alexander A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oafa53akn0updk0f5qsc3aedl5